BioCentury
ARTICLE | Clinical News

Vericiguat: Phase II data

November 23, 2015 8:00 AM UTC

Bayer AG (Xetra:BAYN), Leverkusen, Germany Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Product: Vericiguat ( BAY102, BAY 1021189) Business: Cardiovascular Molecular target: Soluble guanylate cyc...